A recent case report by Noe et al1 described a young man who endorsed bupropion misuse by insufflation and presented with mania following an overdose. This case highlights the need to increase awareness about bupropion misuse.1 Medications with misuse potential include gabapentinoids, anticholinergics, antipsychotics, and antidepressants.2 Bupropion misuse is gaining popularity and is of growing concern.2,3 Bupropion is approved for the treatment of major depressive disorder, seasonal affective disorder, and smoking cessation.2 It is sometimes preferred over selective serotonin reuptake inhibitors due to lack of sexual dysfunction and its weight-neutral profile.4 It is also used off label for attention-deficit disorder.5 Since most misusers will seek a prescription, prescribers must be aware of its misuse potential and related complications.6
Prescribers can suspect bupropion misuse in patients who insist on a bupropion prescription or seek out multiple prescribers.4 Red flags of misuse include euphoria, excess energy, insomnia, and previous illicit drug use.4 Physical clues manifest as nonhealing skin ulcers, damage to nostrils, and new-onset unexplained seizures.3,4 In the United States, young males are at particular risk to misuse bupropion.7 Street names such as “wellies,” “dubs,” “welbys,” and “barnies” may exhibit regional variations with highest prevalence in California, New England, Utah, and New Mexico.2,5 Oral bupropion undergoes extensive first-pass hepatic metabolism, which is why recreational users prefer nasal insufflation or injection due to immediate absorption and higher plasma levels, leading to euphoria.8 The effect of bupropion when insufflated resembles the effects of cocaine with less intensity,8 hence the term poor person’s cocaine as described by Noe and colleagues.1
Parenteral routes make toxic effects more likely due to increased serum concentration.5 These patients are more frequently admitted to critical care compared to other routes.5 The main undesirable effects are dose dependent seizures, usually present at a median dose of about 4.4 g.9 In terms of cardiovascular effects, bupropion overdose can cause QRS and corrected QT interval prolongation, potentially leading to ventricular dysrhythmias and cardiovascular collapse.4
Careful documentation and tracking of bupropion prescriptions is important to identify potential misuse. From a public health perspective, adding bupropion to state prescription monitoring programs could help identify misuse.6 In the meantime, prescribers should be aware of the misuse potential of this medication and screen appropriately. Further research is needed to identify the epidemiologic and clinical impact of a poor person’s cocaine in high risk populations.
Department of Psychiatry, University of Connecticut, Farmington, Connecticut
School of Health Sciences, Quinnipiac University, Hamden, Connecticut
Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
References (9)
Noe G, Martin SO, Shah K, et al. “Poor person’s cocaine”: bupropion insufflation inducing manic symptoms and its abuse potential in dual diagnosis patients. Prim Care Companion CNS Disord. 2023;25(6):23cr03557. PubMedCrossRef
Schifano F, Chiappini S. Is there a potential of misuse for venlafaxine and bupropion? Front Pharmacol. 2018;9:239. PubMedCrossRef
Sugnet T, Jonovska S, Šendula-Jengić V. Delusional infestation due to intravenous abuse of bupropion: case report. Psychiatr Danub. 2021;33(suppl 4):1233–1234. PubMed
Pereira S, Simas J, Mota P, et al. Bupropion misuse by nasal insufflation with a fatal outcome: case report and review. Actas Esp Psiquiatr. 2023;51(2):84–87. PubMed
Stassinos GL, Klein-Schwartz W. Bupropion “abuse” reported to US poison centers. J Addict Med. 2016;10(5):357–362. PubMedCrossRef
Debeltz B. Educational intervention for bupropion abuse prevention. J Dr Nurs Pract. 2021;14(1):34. CrossRef
Aikoye S, Basiru TO, Nwoye I, et al. A systematic review of abuse or overprescription of bupropion in American prisons and a synthesis of case reports on bupropion abuse in American prison and non prison systems. Cureus. 2023;15(3):e36189. PubMedCrossRef